Pancreatic Cancer

SHANGHAI, China, July 27, 2026 IMPACT Therapeutics announced the nomination of IMP3201 as a preclinical candidate (PCC), marking the...

MELBOURNE, Australia, July 30, 2026 Amplia Therapeutics announced the online publication of comprehensive preclinical findings evaluating narmafotinib in pancreatic...

Newcastle, UK, July 30, 2026 Iksuda Therapeutics has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)...

SOUTH SAN FRANCISCO, Calif., July 27, 2026 IDEAYA Biosciences announced the initiation of Part 2 monotherapy expansion in its...

MIRAMAR, Fla., July 23, 2026 HCW Biologics Inc. announced a significant advancement in the development of its proprietary tetravalent...

THE WOODLANDS, Texas, July 23, 2026 Autonomix Medical, Inc. announced that it has been granted U.S. Patent No. 12,471,776,...

Revolution Medicines, Redwood City, Calif., July 22, 2026 Revolution Medicines announced that the U.S. Food and Drug Administration (FDA)...

RAMAT GAN, Israel, July 20, 2026 Can-Fite BioPharma Ltd. (NYSE American: CANF) announced that positive Phase 2a clinical trial...

WILMINGTON, Del., July 17, 2026 Incyte has announced that it will present six oncology studies, including four rapid oral...

Ramat Gan, Israel, July 14, 2026 Can-Fite BioPharma announced that the Australian Patent Office has allowed Patent Application No....